RAK-GOV-MEDIA-OFFICE
12.3.2024 14:33:29 CET | Business Wire | Press release
Steeped in 7,000 years of history, the UAE’s ‘Nature Emirate’ Ras Al Khaimah is undergoing an unprecedented period of economic growth, with tourism, real estate and sustainability taking center stage. Within this dynamic ecosystem, Ras Al Khaimah Art has flourished to become the Emirate’s landmark celebration of culture and the arts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312427377/en/
Featuring works from 107 local and international artists and welcoming 45,000 visitors from around the world, Ras Al Khaimah Art 2024 has successfully concluded its 12th edition at the restored Al Jazeera Al Hamra Heritage Village. Launching as a three-day art exhibition in 2013, Ras Al Khaimah Art has evolved into a month-long annual event and the UAE’s largest outdoor art festival, showcasing Ras Al Khaimah’s vibrant cultural heritage and reflecting the Emirate’s unprecedented cross-sector economic growth. (Photo: AETOSWire)
Inspired by the vision of H.H. Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, the festival was conceived to showcase the Emirate’s artistic talent and foster cultural exchange. Launching at Ras Al Khaimah’s National Museum in 2013 as a three-day exhibition, Ras Al Khaimah Art has evolved into a month-long annual event, welcoming 106 local and international artists from 35 countries in 2024, alongside 45,000 visitors.
Vision & Teamwork
Founding Executive Director of the Al Qasimi Foundation and Ras Al Khaimah Art organiser, Dr. Natasha Ridge acknowledged the event’s potential early on and explored avenues for expansion. During a visit to La Gacilly in France, she encountered a village transformed into an outdoor art gallery and envisioned a similar concept for Ras Al Khaimah Art: “I knew the perfect place.”
Listed on UNESCO’s tentative list of World Heritage Sites, Al Jazeera Al Hamra Heritage Village is the UAE’s last-surviving pearl-fishing village, representing centuries of architecture, trade and culture. Encompassing a fort, watchtowers, a mosque, souq and traditional dwellings, the magical site is defined by a labyrinth of stone alleyways and today, by Ras Al Khaimah Art.
“It’s not just an art festival, it’s also a historical site, which attracts a much wider audience,” says Dr. Ridge.
Ras Al Khaimah Art’s repertoire has expanded to include a range of artistic expressions, from workshops and film screenings to live performances and an art exploration program. “Last year, we saw 1000 students participate in workshops and tours. By connecting our youth with history and culture, we adopt a sustainable approach to the arts,” says Dr. Ridge.
Cultivating Global Connections
Ras Al Khaimah Art plays a pivotal role in promoting Ras Al Khaimah as a cultural destination. By providing a platform for local artists alongside international counterparts, Ras Al Khaimah Art also contributes to the cultural and economic progress of the UAE.
Read more: www.rakart.ae/2024-festival
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312427377/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom